Champions Oncology, Inc.

NASDAQ:CSBR

Biotechnology

Healthcare
$4.59 -1.17%

-$0.08 today

Market cap
$63.91M
Beta
0.40
P/E (TTM)
-41.0
EPS (TTM)
-$0.16
52W Low $5.50High $9.63

Volume 0.00M

Average 0.01M

Returns on capital

Champions Oncology, Inc. management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management
Older years hidden. Sign in to unlock

ROE

124.6%

avg -5009.6%

ROIC

48.6%

avg -339.1%

ROA

14.5%

avg -39.0%

Analysis

ROE is currently the strongest return metric at 124.6% versus its period average of -5009.6%. 3 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

Ronnie Morris

Executive ChairUSD 810.7K60858.88K6.18%

Robert Brainin

Chief Executive Officer & DirectorUSD 516.42K55——

David Barry Miller

Chief Financial OfficerUSD 340K570<0.01%

Maria Mancini

Chief Operating Officer————

Marianna Zipeto

Executive Vice President of Growth, Strategy & Enablement————

Compensation is shown in the reported currency; data updated Nov 7, 2026.

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Mar 17, 2023.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

No open-market purchases or sales in the last 12 months.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/A+104.3%
N/A0 analysts
RevenueN/AN/A+5.1%
+7.5% (3yr)1 analysts
Net IncomeN/AN/A+104.7%
N/A1 analysts
EBITN/AN/A+99.9%
N/A —

Analysis

Recent growth has been strongest in Net Income at +104.7% over three years. Forward estimates point to Revenue at +7.5% (3yr), giving you a quick check on whether expectations are accelerating or cooling.

Competitors

Who does Champions Oncology, Inc. compete with?

Open similar companies to compare how their management teams allocate capital.

Questions

Management questions

Common questions about CSBR's management, answered from reported figures.

Who manages CSBR?

Champions Oncology, Inc. (CSBR) lists 5 active executives. The top listed executive is Maria Mancini, Chief Operating Officer.

Are CSBR insiders buying or selling?

Recent insider activity shows net buying of $6.30M.